Core Viewpoint - The company is transitioning from a "provider of intelligent solutions in the life sciences" to an "AI technology service company based on health industry data elements and ecological resources" [1] Group 1: Strategic Upgrade - The strategic upgrade from "data technology services" to "AI decision-making and intelligent services" is based on a comprehensive capability of "data + model + scenario + ecology" [1] - The company is developing dual-domain large models: (1) Zhuo Mu Niao (medical large model) trained on medical literature, case histories, and pharmaceutical knowledge graphs, evaluated by medical experts for enhanced professionalism and accuracy; (2) Tian Gong Yi Hao (decision-making large model) integrates diverse market data and industry logic with medical knowledge to create marketing strategies and resource allocation plans [1] Group 2: Data Resources and Industry Insights - The company possesses a diverse range of health industry data resources covering medical institutions, health check-up centers, and pharmacies, creating a comprehensive data system from hospitals to outpatient services and from prevention to treatment [1] - With 18 years of industry know-how, the company decodes the business logic behind the data and dissects complex business scenarios to assist in key decision-making [1] Group 3: AI Service System and Team Collaboration - The company has established a complete AI service system from foundational to front-end applications, capable of meeting diverse needs from SMEs to large corporate clients [2] - The team and partners combine top-tier AI technology with extensive pharmaceutical experience, ensuring the integration of technology with medical scenarios to create quantifiable value [2] Group 4: Core Scenarios for AI Implementation - The company aims to drive industry transformation by leveraging its core capabilities in four key scenarios: health industry marketing, medical services, pharmacies, and health management [2] - In marketing, the company is launching commercial AI agents based on the "Tian Gong Yi Hao" decision model for more efficient marketing strategy generation [2] - In the medical sector, the focus will be on developing the "iMDT" intelligent agent for multidisciplinary consultations to enhance decision quality for doctors and hospitals [2] - For pharmacies, the company will enhance professional service capabilities across five dimensions: operational insights, products, diseases, membership, and staff to achieve intelligent management [2] - In health management, the company is committed to developing a comprehensive "prevention-screening-intervention" health management system through a matrix of intelligent agents [2] Group 5: Future Development - The company will adhere to its established development strategy, building an efficient collaborative ecosystem of health industry intelligent agents based on industrial-level data, leading the industry into a new era of intelligence [3]
中康控股公司战略将由“生命科学领域数智化解决方案提供商”升级迈向“以健康产业数据要素和生态资源为基础的AI科技服务公司”